Clemson B, Gaul L, Gubin S S, Campsey D M, McConville J, Nussberger J, Zelis R
Department of Medicine, Pennsylvania State University College of Medicine, Hershey 17033.
J Clin Invest. 1994 Feb;93(2):684-91. doi: 10.1172/JCI117021.
To determine if peripheral angiotensin II (Ang II) prejunctional receptors facilitating NE release exist in humans, we used [3H]NE kinetic methodology to measure forearm NE spillover during intrabrachial arterial Ang II infusions in eight normal male subjects. We used the following protocol to optimize conditions for demonstrating these receptors: (a) lower body negative pressure (-15 mmHg) to increase sympathetic nerve activity to skeletal muscle; and (b) intraarterial nitroprusside to maintain a high constant forearm blood flow (approximately 10 ml/min.100 ml) to maximize the proportion of neuronally released NE that spills over into the circulation. During lower body negative pressure, the following were infused intraarterially for three consecutive 20-min periods: saline, Ang II (4 ng/min), and Ang II (16 ng/min). During the Ang II infusions, forearm venous NE increased significantly from 173 to 189 and 224 pg/ml (P < 0.01), and forearm NE spillover increased from 384 to 439 and 560 ng/min.100 ml (P < 0.05 for high Ang II). Forearm NE clearance was unchanged. During low and high dose Ang II, the plasma venous Ang II concentrations were 25 and 97 pM, respectively. Since normal subjects increase plasma Ang II from 4 to 20-22 pM with exercise, standing, or diuretic administration, and patients with severe congestive heart failure can have a plasma Ang II of approximately 25 pM at rest, we suggest that Ang II might facilitate NE release in severe congestive heart failure, especially under conditions of stress.
为了确定人体内是否存在促进去甲肾上腺素(NE)释放的外周血管紧张素II(Ang II) prejunctional受体,我们采用[3H]NE动力学方法,在8名正常男性受试者的肱动脉内输注Ang II期间测量前臂NE溢出量。我们采用以下方案来优化显示这些受体的条件:(a)下体负压(-15 mmHg)以增加对骨骼肌的交感神经活动;(b)动脉内输注硝普钠以维持较高且恒定的前臂血流量(约10 ml/min·100 ml),以使神经元释放的NE溢出到循环中的比例最大化。在下体负压期间,连续三个20分钟内动脉内输注以下物质:生理盐水、Ang II(4 ng/min)和Ang II(16 ng/min)。在输注Ang II期间,前臂静脉NE从173显著增加至189和224 pg/ml(P<0.01),前臂NE溢出量从384增加至439和560 ng/min·100 ml(高剂量Ang II时P<0.05)。前臂NE清除率未改变。在低剂量和高剂量Ang II期间,血浆静脉Ang II浓度分别为25和97 pM。由于正常受试者在运动、站立或使用利尿剂时血浆Ang II从4增加至20 - 22 pM,而重度充血性心力衰竭患者在静息时血浆Ang II约为25 pM,我们认为Ang II可能在重度充血性心力衰竭中促进NE释放,尤其是在应激条件下。